Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Can we use interleukin-6 (IL-6) blockade for coronavirus disease 2019 (COVID-19)-induced cytokine release syndrome (CRS)?
Bingwen Liu, Min Li, Zhiguang Zhou, et al.
Journal of Autoimmunity (2020) Vol. 111, pp. 102452-102452
Open Access | Times Cited: 759

Showing 1-25 of 759 citing articles:

Postmortem examination of COVID‐19 patients reveals diffuse alveolar damage with severe capillary congestion and variegated findings in lungs and other organs suggesting vascular dysfunction
Thomas Menter, Jasmin D. Haslbauer, Ronny Nienhold, et al.
Histopathology (2020) Vol. 77, Iss. 2, pp. 198-209
Open Access | Times Cited: 1217
IL-6 in inflammation, autoimmunity and cancer
Toshio Hirano
International Immunology (2020) Vol. 33, Iss. 3, pp. 127-148
Open Access | Times Cited: 830
Cytokine storm and leukocyte changes in mild versus severe SARS-CoV-2 infection: Review of 3939 COVID-19 patients in China and emerging pathogenesis and therapy concepts
Jin Wang, Mengmeng Jiang, Xin Chen, et al.
Journal of Leukocyte Biology (2020) Vol. 108, Iss. 1, pp. 17-41
Open Access | Times Cited: 720
Effect of Tocilizumab vs Standard Care on Clinical Worsening in Patients Hospitalized With COVID-19 Pneumonia
Carlo Salvarani, Giovanni Dolci, Marco Massari, et al.
JAMA Internal Medicine (2020) Vol. 181, Iss. 1, pp. 24-24
Open Access | Times Cited: 663
Should we stimulate or suppress immune responses in COVID-19? Cytokine and anti-cytokine interventions
Yvan Jamilloux, Thomas Henry, Alexandre Bélot, et al.
Autoimmunity Reviews (2020) Vol. 19, Iss. 7, pp. 102567-102567
Open Access | Times Cited: 651
How COVID-19 induces cytokine storm with high mortality
Shintaro Hojyo, M. Uchida, Kumiko Tanaka, et al.
Inflammation and Regeneration (2020) Vol. 40, Iss. 1
Open Access | Times Cited: 622
COVID-19 infection alters kynurenine and fatty acid metabolism, correlating with IL-6 levels and renal status
Tiffany Thomas, Davide Stefanoni, Julie A. Reisz, et al.
JCI Insight (2020) Vol. 5, Iss. 14
Open Access | Times Cited: 521
COVID-19: Pathogenesis, cytokine storm and therapeutic potential of interferons
Shivraj Hariram Nile, Arti Nile, Jiayin Qiu, et al.
Cytokine & Growth Factor Reviews (2020) Vol. 53, pp. 66-70
Open Access | Times Cited: 423
Methylprednisolone as Adjunctive Therapy for Patients Hospitalized With Coronavirus Disease 2019 (COVID-19; Metcovid): A Randomized, Double-blind, Phase IIb, Placebo-controlled Trial
Christiane Maria Prado Jerônimo, Maria Eduarda Leão de Farias, Fernando Val, et al.
Clinical Infectious Diseases (2020) Vol. 72, Iss. 9, pp. e373-e381
Open Access | Times Cited: 397
Efficacy and safety of tocilizumab in severe COVID-19 patients: a single-centre retrospective cohort study
Corrado Campochiaro, Emanuel Della‐Torre, Giulio Cavalli, et al.
European Journal of Internal Medicine (2020) Vol. 76, pp. 43-49
Open Access | Times Cited: 390
Description of COVID-19 in HIV-infected individuals: a single-centre, prospective cohort
Pilar Vizcarra, Marı́a Jesús Pérez-Elı́as, Carmen Quereda, et al.
The Lancet HIV (2020) Vol. 7, Iss. 8, pp. e554-e564
Open Access | Times Cited: 373
Cytokine storm and COVID-19: a chronicle of pro-inflammatory cytokines
Antonella F. Fara, Zan Mitrev, Rodney Alexander Rosalia, et al.
Open Biology (2020) Vol. 10, Iss. 9
Open Access | Times Cited: 328
Higher mortality of COVID-19 in males: sex differences in immune response and cardiovascular comorbidities
Laura A. Bienvenu, Jonathan Noonan, Xiaowei Wang, et al.
Cardiovascular Research (2020) Vol. 116, Iss. 14, pp. 2197-2206
Open Access | Times Cited: 303
Sex differences in severity and mortality from COVID-19: are males more vulnerable?
Ajay Pradhan, Per‐Erik Olsson
Biology of Sex Differences (2020) Vol. 11, Iss. 1
Open Access | Times Cited: 288
The immune system and COVID-19: Friend or foe?
Fereshteh Yazdanpanah, Michael R. Hamblin, Nima Rezaei
Life Sciences (2020) Vol. 256, pp. 117900-117900
Open Access | Times Cited: 268
COVID-19 associated with pulmonary aspergillosis: A literature review
Chih‐Cheng Lai, Weng-Liang Yu
Journal of Microbiology Immunology and Infection (2020) Vol. 54, Iss. 1, pp. 46-53
Open Access | Times Cited: 226
Androgen Signaling Regulates SARS-CoV-2 Receptor Levels and Is Associated with Severe COVID-19 Symptoms in Men
Ryan M. Samuel, Homa Majd, Mikayla N Richter, et al.
Cell stem cell (2020) Vol. 27, Iss. 6, pp. 876-889.e12
Open Access | Times Cited: 226
Deciphering the COVID‐19 cytokine storm: Systematic review and meta‐analysis
Rubina Mulchandani, Tanica Lyngdoh, Ashish Kumar Kakkar
European Journal of Clinical Investigation (2020) Vol. 51, Iss. 1
Open Access | Times Cited: 219
Pilot trial of high-dose vitamin C in critically ill COVID-19 patients
Jing Zhang, Xin Rao, Yiming Li, et al.
Annals of Intensive Care (2021) Vol. 11, Iss. 1
Open Access | Times Cited: 216
Natural history of COVID-19 and current knowledge on treatment therapeutic options
Wagner Gouvêa dos Santos
Biomedicine & Pharmacotherapy (2020) Vol. 129, pp. 110493-110493
Open Access | Times Cited: 212
Coagulation and anticoagulation in COVID-19
Tarik Hadid, Zyad Kafri, Ayad Al-Katib
Blood Reviews (2020) Vol. 47, pp. 100761-100761
Open Access | Times Cited: 212
SARS-CoV-2 infection induces a pro-inflammatory cytokine response through cGAS-STING and NF-κB
Christopher J. Neufeldt, Berati Cerikan, Mirko Cortese, et al.
Communications Biology (2022) Vol. 5, Iss. 1
Open Access | Times Cited: 206
Serum Proteomics in COVID-19 Patients: Altered Coagulation and Complement Status as a Function of IL-6 Level
Angelo D’Alessandro, Tiffany Thomas, Monika Dzieciątkowska, et al.
Journal of Proteome Research (2020) Vol. 19, Iss. 11, pp. 4417-4427
Open Access | Times Cited: 191
Interleukin-6 in Rheumatoid Arthritis
Franco Pandolfi, Laura Franza, Valentina Carusi, et al.
International Journal of Molecular Sciences (2020) Vol. 21, Iss. 15, pp. 5238-5238
Open Access | Times Cited: 190
Two important controversial risk factors in SARS-CoV-2 infection: Obesity and smoking
Ayşe Başak Engin, Doruk Engin, Atilla Engin
Environmental Toxicology and Pharmacology (2020) Vol. 78, pp. 103411-103411
Open Access | Times Cited: 183
Page 1 - Next Page

Scroll to top